\n<\/p>\n
Tuesday\u2019s move tracked a sector-wide cannabis rally after President Donald Trump signaled he is considering an executive order to reclassify marijuana. Investors are watching potential U.S. policy changes that could meaningfully impact industry growth. The S&P 500<\/strong> (SNPINDEX:^GSPC)<\/span> slipped 0.26% to 6,799, while the Nasdaq<\/a> Composite<\/strong> (NASDAQINDEX:^IXIC)<\/span> added 0.23% to finish at 23,111. <\/p>\n Within the sector, cannabis-focused peers Canopy Growth (NASDAQ:CGC)<\/span> and Cronos Group (NASDAQ:CRON)<\/span> rose 10.24% and 3.61%, underscoring how U.S. rescheduling speculation is lifting the group.<\/p>\n Today’s jump has Tilray shares approaching a two-month high. Investors are betting that President Trump’s comment that he is “strongly” considering reclassifying marijuana<\/a> from a Schedule I to a Schedule III drug has investors pouring into cannabis names. <\/p>\n An executive order to reclassify the drug to the level of other drugs including Tylenol with Codeine and steroids would increase Tilray’s addressable market<\/a>. It could allow for medical use under federal law for the first time, for example. It’s not the first time the potential for reclassification has come up, though. Investors today seem to believe that this is the time for the official change. <\/p>\n When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor\u2019s<\/em> total average return is 962%* \u2014 a market-crushing outperformance compared to 193% for the S&P 500.<\/p>\n They just revealed what they believe are the 10 best stocks<\/strong><\/a> for investors to buy right now, available when you join <\/span><\/span>Stock Advisor.<\/span><\/i><\/strong><\/p>\n See the stocks \u00bb<\/a><\/strong><\/p>\n *Stock Advisor returns as of December 16, 2025. <\/em><\/p>\n Howard Smith<\/a> has positions in Tilray Brands. The Motley Fool has positions in and recommends Cronos Group. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy<\/a>.<\/em><\/p>\n The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.\n <\/div>\n Tilray Brands (NASDAQ:TLRY), global medical cannabis producer, closed Tuesday\u2019s session at $13.94, up 27.54%. Trading volume reached 46.8 million shares, about 525% above its three-month average of 8.9 million shares. How the markets moved today Tuesday\u2019s move tracked a sector-wide cannabis rally after President Donald Trump signaled he is considering an executive order to reclassify … Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":5233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[],"class_list":["post-13789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.jubi24.com\/wp-content\/uploads\/2025\/10\/Intel-Shareholders-Got-Amazing-News-From-a-Massive-Competitor.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/posts\/13789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13789"}],"version-history":[{"count":1,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/posts\/13789\/revisions"}],"predecessor-version":[{"id":13790,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/posts\/13789\/revisions\/13790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=\/wp\/v2\/media\/5233"}],"wp:attachment":[{"href":"https:\/\/www.jubi24.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jubi24.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What this means for investors<\/h2>\n
Where to invest $1,000 right now<\/h2>\n
\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"